Patents by Inventor Ada Repetto-Llamazares

Ada Repetto-Llamazares has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210106703
    Abstract: The present invention relates to a combination of radioimmunoconjugates and a protein or molecule capable of leading to progression of the cell cycle through the G2/M checkpoint, a protein or molecule capable of inhibiting progression through Mitosis, a protein or molecule which is a BCL2 inhibitor, or a protein or molecule which is a PARP inhibitor, for use as a medicament. The medicament may be against Non-Hodgkin's lymphoma (NHL).
    Type: Application
    Filed: November 21, 2018
    Publication date: April 15, 2021
    Inventors: Jean Pierre Pouget, Alexandre Pichard, Randi Syljuåsen, Gro Elise Rødland, Helen Heyerdahl, Sebastian Patzke, Jostein Dahle, Ada Repetto-Llamazares, Marion Masita Malenge
  • Patent number: 10646599
    Abstract: The present invention relates to radioimmunoconjugates that are capable of upregulating expression of one or more antigens. The upregulated antigens can be the antigens that are targeted by the radioimmunoconjugates or different antigens expressed on the same cells. The present invention also relates to methods of treating cancer and diseases and disorders of the immune system by utilizing this enhanced expression of antigens.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: May 12, 2020
    Assignee: NORDIC NANOVECTOR ASA
    Inventors: Roy H. Larsen, Ada Repetto-Llamazares
  • Publication number: 20190008989
    Abstract: The present invention relates to radioimmunoconjugates that are capable of upregulating expression of one or more antigens. The upregulated antigens can be the antigens that are targeted by the radioimmunoconjugates or different antigens expressed on the same cells. The present invention also relates to methods of treating cancer and diseases and disorders of the immune system by utilizing this enhanced expression of antigens.
    Type: Application
    Filed: June 13, 2018
    Publication date: January 10, 2019
    Inventors: Roy H. Larsen, Ada Repetto-Llamazares
  • Publication number: 20160101199
    Abstract: The present invention relates to radioimmunoconjugates that are capable of upregulating expression of one or more antigens. The upregulated antigens can be the antigens that are targeted by the radioimmunoconjugates or different antigens expressed on the same cells. The present invention also relates to methods of treating cancer and diseases and disorders of the immune system by utilizing this enhanced expression of antigens.
    Type: Application
    Filed: June 6, 2014
    Publication date: April 14, 2016
    Inventors: Roy H. Larsen, Ada Repetto-Llamazares